|
|
|
|
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
|
Amgen initial purchase March 24, 2014
Amgen with Onyx Pharmaceuticals: Long Term Analysis September 4, 2013
2014 |
|||
4/22/2014 |
07/29/2014 |
||
2013 |
|||
Not available |
|||
07/30/2013 |
10/22/2013 |
01/28/2014 |
|
Amgen Valuation [blog 12/3/2007]
I did not follow Amgen closely between the end of 2008 and mid-2013.
2008 |
|||
 |
|
|
|
Q3 2008 |
Q2 2008 |
Q1 2008 |
Q4 2007 |
10/22/2008 |
07/28/2008 |
04/24/2008 |
1/24/2008 |
2007 |
|||
|
|
|
|
10/24/2007 |
07/26/2007 |
4/23/2007 |
|
Q3 2007 |
Q2 2007 |
Q1 2007 |
|
Amgen is a biotechnology therapeutics company selling a variety of drugs, notably Arenesp, Epogen and Enbrel.
Amgen Web site:
Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but its possible. Before making or terminating an investment you should always verify any factual basis of your decision.